ONE STAGE CHRONOMETRIC FVIII ASSAY OR TWO STAGE CHROMOGENIC FVIII ASSAY TO DIAGNOSE HAEMOPHILIA A?

被引：0
|
作者：
Marchand, K. [1 ]
Benoit, R. [1 ]
Martin, M. [2 ]
Fretigny, M. [3 ]
Toussaint-Hacquard, M. [1 ]
Frotscher, B. [2 ]
机构：
[1] Univ Hosp Nancy, Lab Haematol, Vandoeuvre Les Nancy, France
[2] Univ Hosp Nancy, Haemophilia Treatment Ctr, Vandoeuvre Les Nancy, France
[3] Univ Hosp Lyon, Lab Genet, Lyon, France
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO012
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] A sensitive and specific chromogenic assay for the detection of "functional FVIII inhibitors"
    Ghosh, K.
    Pinto, P.
    Kulkarni, B.
    Shetty, S.
    HAEMOPHILIA, 2010, 16 : 72 - 72
  • [22] A comparison of the VisuLize™ FVIII antigen assay with the COAMATICR FVIII functional assay
    Ali, ES
    Angeloni, F
    Lauzon, M
    Johnston, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 96 - 97
  • [23] ASSAY DISCREPANCY IN MILD HAEMOPHILIA A PATIENTS WITH MUTATIONS IN FVIII A DOMAIN
    Bakija, A. Trampus
    Debeljak, M.
    Kovac, J.
    Zupan, I. Preloznik
    Jazbec, J.
    HAEMATOLOGICA, 2016, 101 : 306 - 306
  • [24] Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients
    Pouplard, C.
    Ternisien, C.
    Desconclois, C.
    Lasne, D.
    Aillaud, M. -F.
    Caron, C.
    HAEMOPHILIA, 2016, 22 (02) : E101 - E103
  • [25] A blinded in vitro study with Refacto® mock plasma samples:: similar FVIII results between the chromogenic assay and a one-stage assay when using a higher cephalin dilution
    Caron, C
    Dautzenberg, MD
    Delahousse, B
    Droulle, C
    Pouzol, P
    Dubanchet, A
    Rothschild, C
    HAEMOPHILIA, 2002, 8 (05) : 639 - 643
  • [26] ARE ONE STAGE AND CHROMOGENIC FVIII:C ASSAYS SUITABLE FOR MEASUIRNG ADYNOVI IN SPIKED PLASMA?
    Guy, S.
    Oliver-Newman, E.
    Bowyer, A.
    Kitchen, S.
    HAEMOPHILIA, 2023, 29 : 27 - 27
  • [27] VERIFICATION AND COMPARISON OF CHROMOGENIC FVIII ASSAY IN HEMOPHILIA PATIENTS WITH/WITHOUT EMICIZUMAB
    Lee, MinYoung
    Lee, Woo In
    Kang, So Young
    Kim, Myeong Hee
    Park, Young Shil
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 102 - 103
  • [28] Comparison of FVIII activity of select novel recombinant FVIII replacement products in commonly used FDA approved one-stage clot assay systems
    Tiefenbacher, S.
    Robinson, M. M.
    Ross, E. L.
    Williams, P. T.
    Cogswell, C. E.
    Wham, T. L.
    Chow, G. K.
    Adcock, D. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 566 - 566
  • [29] Prevalence of discrepancy between one-stage and chromogenic FVIII activity assays and the mutation profile in Polish mild/moderate haemophilia A patients
    Baran, Beata
    Odnoczko, Edyta
    Stefanska-Windyga, Ewa
    Pavlova, Anna
    Oldenburg, Johannes
    Windyga, Jerzy
    HAEMOPHILIA, 2016, 22 : 75 - 75
  • [30] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Salaj, P.
    Hrachovinova, I.
    HAEMOPHILIA, 2015, 21 (04) : E330 - E332
12345